These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 9578088)
21. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification. Kalyan K; Basu D; Soundararaghavan J Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715 [TBL] [Abstract][Full Text] [Related]
22. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [TBL] [Abstract][Full Text] [Related]
23. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Ni X; Hazarika P; Zhang C; Talpur R; Duvic M Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580 [TBL] [Abstract][Full Text] [Related]
24. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Raphael M; Gentilhomme O; Tulliez M; Byron PA; Diebold J Arch Pathol Lab Med; 1991 Jan; 115(1):15-20. PubMed ID: 1987908 [TBL] [Abstract][Full Text] [Related]
25. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065 [TBL] [Abstract][Full Text] [Related]
26. Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas. Pals ST; Meijer CJ; Radaszkiewicz T Leukemia; 1991 Jul; 5(7):628-31. PubMed ID: 2072751 [TBL] [Abstract][Full Text] [Related]
27. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas. Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418 [TBL] [Abstract][Full Text] [Related]
28. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366 [TBL] [Abstract][Full Text] [Related]
29. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma. de Larrinoa AF; del Cura J; Zabala R; Fuertes E; Bilbao F; Lopez JI J Clin Ultrasound; 2007; 35(6):295-301. PubMed ID: 17486566 [TBL] [Abstract][Full Text] [Related]
30. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Ong ST; Le Beau MM Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595 [TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas. Ozbudak IH; Akkaya B; Karpuzoğlu G Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma. Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995 [TBL] [Abstract][Full Text] [Related]
34. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688 [TBL] [Abstract][Full Text] [Related]
35. T cell rich B cell lymphoma (TCRBCL): study of sixteen cases with review of literature. Muzaffar S; Pervez S; Kayani N; Soomro IN; Hasan SH Indian J Pathol Microbiol; 1999 Jan; 42(1):15-23. PubMed ID: 10420680 [TBL] [Abstract][Full Text] [Related]
36. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer. Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988 [TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma]. Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251 [TBL] [Abstract][Full Text] [Related]
38. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates. Magro CM; Dyrsen ME J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860 [TBL] [Abstract][Full Text] [Related]
39. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes. Büssing A; Stein GM; Pfüller U; Schietzel M Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116 [TBL] [Abstract][Full Text] [Related]
40. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Gustmann C; Altmannsberger M; Osborn M; Griesser H; Feller AC Am J Pathol; 1991 Jun; 138(6):1413-22. PubMed ID: 1711289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]